Market Overview - CPhI...VIETNAM 5% Latest Updates Source: • World Health Organization & OECD –...
1
Market Overview Economic prosperity, aging population, the growing middle- income population and sensitive public policy are key pharma- demand drivers in South East Asia THAILAND Pharma Companies 395 Import US$ 14.16 million Export US$ 93.66 million VIETNAM Pharma Companies 442 Import US$ 24.19 million Export US$ 93.66 million MALAYSIA Pharma Companies 371 Import US$ 18.88 million Export US$ 93.66 million PHILIPPINES Pharma Companies 117 Import US$ 28.31 million Export US$ 93.66 million INDONESIA Pharma Companies 272 Import US$ 11.28 million Export US$ 93.66 million SINGAPORE Pharma Companies 51 Import US$ 15.85 million Export US$ 93.66 million Opportunites Aging population Raising burden of chronic diseases Inexpensive medical devices Ongoing improvements to the regulatory environment R&D commitment through strategic partnerships Challenges Government control pricing and generic substitution policies Weak intellectual property protection Statistics by Country Expenditure by Country n Pharmaceutical expenditure US$ / Capita (PPP) 0 $100 $200 $300 $400 $500 $600 US$103.9 INDONESIA MALAYSIA PHILIPPINES THAILAND VIETNAM US$198.8 US$109.4 US$599.84 US$123.7 Total Pharmaceutical Expenditure n Public vs n Private INDONESIA 14.3% vs 85.7% MALAYSIA 54.3% vs 45.7% PHILIPPINES 15% vs 85% THAILAND 90.6% vs 9.4% VIETNAM 16.5% vs 83.5% VAT on Medicine INDONESIA 10% MALAYSIA 6% PHILIPPINES 12% THAILAND 7% VIETNAM 5% Latest Updates Source: • World Health Organization & OECD – How pharmaceutical systems are organized in Asia and the Pacific • Asia, Pharmaceutical & Healthcare Report Q2 2019, Fitch Solutions • Deloitte – A perspective of future healthcare landscape in ASEAN and Singapore • International Journal of Drug Regulatory Affairs – A critical view of harmonization of regulatory requirements for Generic Drug approval submissions in ASEAN countries Singapore’s Finance Minister Heng Swee Keat released Singapore’s FY2019/20 budget ‘Building a Strong, United Singapore’. For senior citizens, the government set aside SGD6.1bn (USD4.5bn) in this budget for a newly set up Merdeka Generation Fund that will benefit more than 500,000 senior citizens. The Philippines President Rodrigo Duterte officially signed the Universal Health Care Act into law, which guarantees equitable access to quality and affordable healthcare services for all Filipinos. The Vietnam National Heart Association signed an agreement with Merck Export GMBH to implement the Continuing Medical Education Program New Concept programme for the 2019-2021 term. The Thai drug market is dominated by foreign pharma companies. By 2022, the pharmaceutical market in Thailand is predicated to double, thanks to trade negotiations, regional harmonization and positive economic trends.
Transcript of Market Overview - CPhI...VIETNAM 5% Latest Updates Source: • World Health Organization & OECD –...
Market OverviewEconomic prosperity, aging population, the growing middle-income population and sensitive public policy are key pharma-demand drivers in South East Asia
THAILANDPharma
Companies395
ImportUS$ 14.16
millionExport
US$ 93.66 million
VIETNAMPharma
Companies442
ImportUS$ 24.19
millionExport
US$ 93.66 million
MALAYSIAPharma
Companies371
ImportUS$ 18.88
millionExport
US$ 93.66 million
PHILIPPINESPharma
Companies117
ImportUS$ 28.31
millionExport
US$ 93.66 million
INDONESIAPharma
Companies272
ImportUS$ 11.28
millionExport
US$ 93.66 million
SINGAPOREPharma
Companies51
ImportUS$ 15.85
millionExport
US$ 93.66 million
Opportunites
Aging population
Raising burden of chronic diseases
Inexpensive medical devices
Ongoing improvements
to the regulatory environment
R&D commitment
through strategic
partnerships
ChallengesGovernment control pricing and generic substitution policies
Weak intellectual property protection
Statistics by Country
Expenditure by Country
n Pharmaceutical expenditure US$ / Capita (PPP)
0
$100
$200
$300
$400
$500
$600
US$103.9
INDONESIA MALAYSIA PHILIPPINES THAILAND VIETNAM
US$198.8
US$109.4
US$599.84
US$123.7
Total Pharmaceutical Expendituren Public vs n Private
0
$100
$200
$300
$400
$500
$600
US$103.9
INDONESIA MALAYSIA PHILIPPINES THAILAND VIETNAM
US$198.8
US$109.4
US$599.84
US$123.7
INDONESIA
14.3% vs 85.7%
0
$100
$200
$300
$400
$500
$600
US$103.9
INDONESIA MALAYSIA PHILIPPINES THAILAND VIETNAM
US$198.8
US$109.4
US$599.84
US$123.7
MALAYSIA
54.3% vs 45.7%
0
$100
$200
$300
$400
$500
$600
US$103.9
INDONESIA MALAYSIA PHILIPPINES THAILAND VIETNAM
US$198.8
US$109.4
US$599.84
US$123.7
PHILIPPINES
15% vs 85%
0
$100
$200
$300
$400
$500
$600
US$103.9
INDONESIA MALAYSIA PHILIPPINES THAILAND VIETNAM
US$198.8
US$109.4
US$599.84
US$123.7
THAILAND
90.6% vs 9.4%
0
$100
$200
$300
$400
$500
$600
US$103.9
INDONESIA MALAYSIA PHILIPPINES THAILAND VIETNAM
US$198.8
US$109.4
US$599.84
US$123.7
VIETNAM
16.5% vs 83.5%
VAT on Medicine
INDONESIA
10%
MALAYSIA
6%PHILIPPINES
12%
THAILAND
7%
VIETNAM
5%
Latest Updates
Source:
• World Health Organization & OECD – How pharmaceutical systems are organized in Asia and the Pacific
• Asia, Pharmaceutical & Healthcare Report Q2 2019, Fitch Solutions
• Deloitte – A perspective of future healthcare landscape in ASEAN and Singapore • International Journal of Drug Regulatory Affairs – A critical view of harmonization of
regulatory requirements for Generic Drug approval submissions in ASEAN countries
Singapore’s Finance Minister Heng Swee Keat released Singapore’s FY2019/20 budget ‘Building a Strong, United Singapore’. For senior citizens, the government set aside SGD6.1bn (USD4.5bn) in this budget for a newly set up Merdeka Generation Fund that will benefit more than 500,000 senior citizens.
The Philippines President Rodrigo Duterte officially signed the Universal Health Care Act into law, which guarantees equitable access to quality and affordable healthcare services for all Filipinos.
The Vietnam National Heart Association signed an agreement with Merck Export GMBH to implement the Continuing Medical Education Program New Concept programme for the 2019-2021 term.
The Thai drug market is dominated by foreign pharma companies. By 2022, the pharmaceutical market in Thailand is predicated to double, thanks to trade negotiations, regional harmonization and positive economic trends.
